What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release?
What are critical considerations on drug-device integrated development and how to choose the right regulatory and clinical strategy?
How to better adapt smart manufacturing in pharma and boost the opportunities offered by emerging technologies?